Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...

Real-world data from 2016 to 2025 highlight the changing landscape of biologic use and the growing preference for tezepelumab in asthma.

New York City’s Mold Busters program is associated with thousands fewer emergency department visits for asthma per year, ...

Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 AAAAI Annual Meeting.

A new study is offering children with asthma an enhanced check-up to see whether it can bring down the overuse of inhalers.

Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids. HealthDay News — In a clinical practice guideline issued ...

Please provide your email address to receive an email when new articles are posted on . The questionnaire assessed general fatigue, sleep-rest fatigue and cognitive fatigue. Asthma-related quality of ...

Please provide your email address to receive an email when new articles are posted on . BATURA showed a 47% reduction in severe exacerbation risk with albuterol budesonide vs. albuterol in patients ...

Add Yahoo as a preferred source to see more of our stories on Google. Everyone coughs and sneezes occasionally, and it's hard to get through peak upper-respiratory virus season without catching a cold ...

New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma ...

The use of polluting household fuels and gas was associated with an increased likelihood of eczema, followed by severe asthma ...